The Wall Street Journal @WSJ
Doctors in countries including Australia and Japan are prescribing Merck’s less-effective Covid-19 antiviral pill more frequently than Pfizer’s, citing a risk of drug interactions https://t.co/oXWo7C3bWn — PolitiTweet.org